Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Goossens

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|May 10, 2019
ClpP Protease, a Promising Antimicrobial TargetCarlos Moreno-Cinos, Kenneth Goossens, Irene G Salado, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 2016
Monitoring the stability of the standardization status of FT4 and TSH assays by use of daily outpatient medians and flagging frequenciesLinde A C De Grande, Kenneth Goossens, Katleen Van Uytfanghe, et al.
Clinical Chemistry and Laboratory Medicine|July 23, 2016
Using "big data" to describe the effect of seasonal variation in thyroid-stimulating hormoneLinde A C De Grande, Kenneth Goossens, Katleen Van Uytfanghe, et al.
Frontiers in Chemistry|April 24, 2023
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitorsCamilla Scarpellini, Sophie Valembois, Kenneth Goossens, et al.
Journal of Medicinal Chemistry|February 14, 2018
Tozasertib Analogues as Inhibitors of Necroptotic Cell DeathSam Hofmans, Lars Devisscher, Sofie Martens, et al.
Journal of Medicinal Chemistry|October 26, 2018
Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo EfficacyLars Devisscher, Samya Van Coillie, Sam Hofmans, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2025
Structure activity relationship exploration of imidazo[1,2-a]pyridine series to reverse isoform selectivity and identify potent SIK1 selective inhibitorsChristophe Peixoto, Elsa De Lemos, Laëtitia Cherel, et al.
European Journal of Medicinal Chemistry|July 25, 2023
Modulation of taxane binding to tubulin curved and straight conformations by systematic 3'N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potencyYuntao Ma, Fernando Josa-Prado, Jacob Nathaniel Essif, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Journal of Chemical Information and Modeling|February 26, 2026
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery DataHugo MacDermott-Opeskin, Jenke Scheen, Cas Wognum, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|May 10, 2019
ClpP Protease, a Promising Antimicrobial TargetCarlos Moreno-Cinos, Kenneth Goossens, Irene G Salado, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 2016
Monitoring the stability of the standardization status of FT4 and TSH assays by use of daily outpatient medians and flagging frequenciesLinde A C De Grande, Kenneth Goossens, Katleen Van Uytfanghe, et al.
Clinical Chemistry and Laboratory Medicine|July 23, 2016
Using "big data" to describe the effect of seasonal variation in thyroid-stimulating hormoneLinde A C De Grande, Kenneth Goossens, Katleen Van Uytfanghe, et al.
Frontiers in Chemistry|April 24, 2023
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitorsCamilla Scarpellini, Sophie Valembois, Kenneth Goossens, et al.
Journal of Medicinal Chemistry|February 14, 2018
Tozasertib Analogues as Inhibitors of Necroptotic Cell DeathSam Hofmans, Lars Devisscher, Sofie Martens, et al.
Journal of Medicinal Chemistry|October 26, 2018
Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo EfficacyLars Devisscher, Samya Van Coillie, Sam Hofmans, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2025
Structure activity relationship exploration of imidazo[1,2-a]pyridine series to reverse isoform selectivity and identify potent SIK1 selective inhibitorsChristophe Peixoto, Elsa De Lemos, Laëtitia Cherel, et al.
European Journal of Medicinal Chemistry|July 25, 2023
Modulation of taxane binding to tubulin curved and straight conformations by systematic 3'N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potencyYuntao Ma, Fernando Josa-Prado, Jacob Nathaniel Essif, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Journal of Chemical Information and Modeling|February 26, 2026
A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery DataHugo MacDermott-Opeskin, Jenke Scheen, Cas Wognum, et al.
Pageof 2